Download Poster
Download the Annogen AIM™ poster to see how AIM™ technology helps identify optimal genomic sites for transgene expression in cell therapies. This method uses integration mapping to find sites with activation-dependent upregulation, improving safety and effectiveness. Discover the process and how it supports better therapeutic outcomes. Download now to explore the details and contact Annogen for more information.
Annogen today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programs.
Annogen today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for use in certain pre-clinical hematopoietic stem cell (HSC) gene therapy programs.
